Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
Compensation Framework Study
First Interim Report
Second Interim Report
The Inquiry Report
Publication Day
Evidence
Evidence
Hearings Archive
Compensation
Support
Confidential Psychological Support
Interim Payments
Support Groups
Get in touch
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
David Binnie's memo to PS/Secretary of State records Michael Forsyth's concern that compensation did not apply to other groups infected with HIV through blood products.
Published on:
31 July, 2024
J & A Hastie Solicitors wrote to William Waldegrave regarding payments for patients infected with HIV through transfusion.
Published on:
31 July, 2024
David Burrage (Department of Health) responded to J & A Hastie Solicitors letter of 18 December 1990 to William Waldegrave, regarding payments for patients infected with HIV through transfusion.
Published on:
31 July, 2024
J & A Hastie Solicitors wrote to Virginia Bottomley, Minister for Health, with regard to payments for patients infected with HIV through transfusion.
Published on:
31 July, 2024
Richard Henderson, Solicitor's Office, wrote to Mr Panton regarding the Department of Health's reasoning in relation to the differences between those with haemophilia and those infected through transfusion.
Published on:
31 July, 2024
The Observer and Sunday Telegraph published articles which repudiated the Department of Health's claimed distinction between people with haemophilia and people without haemophilia.
Published on:
31 July, 2024
Richard Henderson, Solicitor's Office, advised that the SHHD should move away from the contrasting of whole blood victims with victims with haemophilia.
Published on:
31 July, 2024
Christine Dora told the Inquiry the report prepared following the Scottish Executive investigation was largely finalised by this date.
Published on:
31 July, 2024
Christine Dora felt that no compensation should be awarded unless harm had been done.
Published on:
31 July, 2024
Christine Dora sought advice from Dr Keel regarding the submission by SNBTS and a number of clinical matters.
Published on:
31 July, 2024
In her written statement, Lynda Towers explained that she was a senior solicitor advising the Scottish Executive during this period.
Published on:
31 July, 2024
Health Department officials met to discuss the way forward with the enquiries into the events surrounding the heat treatment of blood products in Scotland between 1985 and 1987.
Published on:
31 July, 2024
Newsletter
Published on:
12 May, 2020
Christine Dora sent a memo to PS/Minister for Health and Community Care noting that the Haemophilia Society had not confined matters to heat treatment between 1985 and 1987 and seeking approval for a revised remit.
Published on:
31 July, 2024
Dr Keel wrote to Scottish Haemophilia Directors informing them that the Haemophilia Society was particularly interested in pursuing with the Scottish Executive inquiry the issue of what patients were told at the time of Hepatitis C testing, including the clinical implications of a positive diagnosis.
Published on:
31 July, 2024
Haemophilia directors attended a meeting along with officials and haemophilia centre directors from across Scotland in order to establish "whether there was a general policy on what patients were told and whether there [was] an assessment of risk and if patients were given a choice."
Published on:
31 July, 2024
At the meeting of Haemophilia directors, officials and haemophilia centre directors from across Scotland a comment was recorded as being made by Dr Henry Watson of Aberdeen Haemophilia Centre that the clinician "would have to make the decision of whether to hand the patient a host of information or outline the benefits/risks of particular products."
Published on:
31 July, 2024
At the meeting of Haemophilia directors, officials and haemophilia centre directors from across Scotland a comment was recorded as being made by Professor Ludlam that DDAVP could have been used from 1979 but that this was a matter of clinical judgement and "patients were desperate at that time to be prescribed concentrate as this allowed them to treat themselves at home."
Published on:
31 July, 2024
At the meeting of Haemophilia directors, officials and haemophilia centre directors from across Scotland, Professor Ludlam sought advice on whether haemophilia directors should be looking back to try and identify what had happened to people whose whereabouts and status were unknown. Lynda Towers referred to the Central Legal Office and said that haemophilia directors should follow their advice on whether any further investigation or tracking down of patients was necessary.
Published on:
31 July, 2024
The Scottish National Blood Transfusion Service sent to the Scottish Executive a paper in response to requests for information from Christine Dora.
Published on:
31 July, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2268
Page
2269
Page
2270
Page
2271
Current page
2272
Page
2273
Page
2274
Page
2275
Page
2276
…
Next page
Next
Last page
Last